Pritesh Shah's most recent trade in NovoCure Ltd was a trade of 382 Ordinary Shares done at an average price of $12.6 . Disclosure was reported to the exchange on Nov. 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 12.65 per share. | 07 Nov 2023 | 382 | 124,511 (0%) | 0% | 12.6 | 4,832 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 21.82 per share. | 01 Sep 2023 | 273 | 124,893 (0%) | 0% | 21.8 | 5,956 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 30 Jun 2023 | 367 | 125,166 (0%) | 0% | 35.3 | 12,948 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 16,909 | 124,799 (0%) | 0% | 76.2 | 1,287,779 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 2,942 | 141,708 (0%) | 0% | 76.2 | 224,061 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 1,570 | 144,650 (0%) | 0% | 76.2 | 119,570 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 43,246 | 146,220 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 3,936 | 102,974 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 75.28 per share. | 02 Mar 2023 | 937 | 99,038 (0%) | 0% | 75.3 | 70,535 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 31,691 | 31,691 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 19,055 | 101,898 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Pritesh Shah | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 76.36 per share. | 28 Feb 2023 | 1,923 | 99,975 (0%) | 0% | 76.4 | 146,845 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 108.00 per share. | 05 Jan 2023 | 387 | 82,843 (0%) | 0% | 108 | 41,796 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 79.04 per share. | 02 Sep 2022 | 269 | 83,230 (0%) | 0% | 79.0 | 21,261 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 59.07 per share. | 05 Jul 2022 | 312 | 83,499 (0%) | 0% | 59.1 | 18,431 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 69.55 per share. | 07 Mar 2022 | 5,294 | 84,389 (0%) | 0% | 69.6 | 368,198 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 70.10 per share. | 07 Mar 2022 | 2,481 | 81,908 (0%) | 0% | 70.1 | 173,918 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 38,027 | 38,027 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 21,714 | 95,226 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 6,231 | 6,231 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 73.34 per share. | 03 Mar 2022 | 2,632 | 91,597 (0%) | 0% | 73.3 | 193,031 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 70.41 per share. | 03 Mar 2022 | 1,914 | 89,683 (0%) | 0% | 70.4 | 134,759 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 03 Mar 2022 | 997 | 94,229 (0%) | 0% | 74.5 | 74,275 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 138.27 per share. | 02 Sep 2021 | 321 | 73,692 (0%) | 0% | 138.3 | 44,386 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 138.23 per share. | 02 Sep 2021 | 156 | 74,013 (0%) | 0% | 138.2 | 21,564 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 139.24 per share. | 02 Sep 2021 | 150 | 73,542 (0%) | 0% | 139.2 | 20,886 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 140.17 per share. | 02 Sep 2021 | 30 | 73,512 (0%) | 0% | 140.2 | 4,205 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 148.71 per share. | 04 Aug 2021 | 2,063 | 74,169 (0%) | 0% | 148.7 | 306,789 | Ordinary Shares |
| NovoCure Ltd | Pritesh Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 149.43 per share. | 03 Aug 2021 | 1,654 | 76,232 (0%) | 0% | 149.4 | 247,157 | Ordinary Shares |